PPARA and cardiomyopathy: Furthermore, a proposal put forward by Young et al. suggests the downregulation of the PPARα/a decrease in PPARα responsiveness in obesity causes an underexpression of fatty acid oxidative enzymes, intracellular lipid development, and cardiomyopathy [29].